CONNECT BIOPHARMA HOLDINGS LTD (CNTB) — insider trading
Health Care · NASDAQ
CONNECT BIOPHARMA HOLDINGS LTD (CNTB) has 6 reported SEC Form 4 insider transactions in our data, including 2 open-market purchases among the most recent 6 (latest 2026-06-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | LIU JEAN I | Director | Grant / award / vesting | 6,718 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Xanthopoulos Kleanthis Gabriel | Director | Grant / award / vesting | 3,738 | $0.00 | $0 | Form 4 |
| 2026-05-29 | Huang James | Director | Open-market purchase | 150,000 | $2.48 | $371.6K | Form 4 |
| 2026-03-31 | LIU JEAN I | Director | Grant / award / vesting | 5,061 | $0.00 | $0 | Form 4 |
| 2026-03-31 | Xanthopoulos Kleanthis Gabriel | Director | Grant / award / vesting | 2,816 | $0.00 | $0 | Form 4 |
| 2026-03-31 | Huang James | Director | Open-market purchase | 1,160,000 | $3.45 | $4.00M | Form 4 |
Ask the chat about CNTB's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CONNECT BIOPHARMA HOLDINGS LTD (CNTB).
Last updated 2026-06-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.